# US 2006/0067959 A1 · Compositions and methods for treatment of solar damage

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0067959 A1
- Document ID: US20060067959A1
- Status: Published application
- Kind: A1
- Application number: 10/951,824
- Filed: 2004-09-28
- Published: 2006-03-30
- Earliest claimed: 2004-09-28
- Inventors: Marcel Nimni; Bo Han; Bruce Sand
- Web page: https://patentgrep.com/patent/US20060067959A1

## CPC

- A61K 8/447: {containing sulfur}
- A61K 8/19: containing inorganic ingredients
- A61K 8/44: Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K 8/492: {having condensed rings, e.g. indol}
- A61K 8/4946: {Imidazoles or their condensed derivatives, e.g. benzimidazoles}
- A61K 8/498: {having 6-membered rings or their condensed derivatives, e.g. coumarin}
- A61K 8/4986: {with sulfur as the only hetero atom}
- A61K 8/64: Proteins; Peptides; Derivatives or degradation products thereof
- A61K 8/676: {Ascorbic acid, i.e. vitamin C}
- A61K 31/198: Alpha-amino acids, e.g. alanine or edetic acid [EDTA] (betaine A61K31/205; proline A61K31/401; tryptophan A61K31/405; histidine A61K31/4172; peptides not degraded to individual amino acids A61K38/00)
- A61K 31/375: Ascorbic acid, i.e. vitamin C; Salts thereof
- A61Q 17/04: Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
- A61Q 19/00: Preparations for care of the skin
- A61K 2800/522: Antioxidants; Radical scavengers
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

An improved composition for treatment of the skin comprises: (1) methionine and cysteine in a quantity sufficient to accelerate restoration of the integrity and fullness of the skin; (2) a mixture of essential amino acids in a quantity sufficient to accelerate restoration of the integrity and fullness of the skin, the mixture comprising isoleucine, leucine, lysine, phenylalanine, threonine, tryptophan, valine, histidine, and arginine; (3) at least one antioxidant in a quantity sufficient to accelerate restoration of the integrity and fullness of the skin; (4) at least one cross-linking agent in a quantity sufficient to accelerate restoration of the integrity and fullness of the skin; (5) at least one metallic catalyst in a quantity sufficient to accelerate restoration of the integrity and fullness of the skin; (6) at least one transepidermal delivery agent in a quantity sufficient to promote delivery of the composition to the skin; and (7) a topical pharmaceutically acceptable carrier. The antioxidant can be ascorbic acid. The cross-linking agent can be proanthocyanidin or silybin. The metallic catalyst can be Cu (II) in a suitable cupric salt. The transepidermal delivery agent can be benzyl alcohol.

## Claims

### Claim 1

A composition for treatment of the skin comprising:
(a) methionine and cysteine in a quantity sufficient to accelerate restoration of the integrity and fullness of the skin;
(b) a mixture of essential amino acids in a quantity sufficient to accelerate restoration of the integrity and fullness of the skin, the mixture of essential amino acids comprising isoleucine, leucine, lysine, phenylalanine, threonine, tryptophan, valine, histidine, and arginine;
(c) at least one antioxidant in a quantity sufficient to accelerate restoration of the integrity and fullness of the skin;
(d) at least one cross-linking agent in a quantity sufficient to accelerate restoration of the integrity and fullness of the skin;
(e) at least one metallic catalyst in a quantity sufficient to accelerate restoration of the integrity and fullness of the skin;
(f) at least one transepidermal delivery agent in a quantity sufficient to promote delivery of the composition to the skin; and
(g) a topical pharmaceutically acceptable carrier.

### Claim 2 (depends on 1)

The composition of claim 1 wherein the at least one antioxidant is selected from the group consisting of lipoic acid or a lipoic acid derivative or analogue and ascorbic acid or a derivative of ascorbic acid.

### Claim 3 (depends on 2)

The composition of claim 2 wherein the antioxidant is lipoic acid.

### Claim 4 (depends on 2)

The composition of claim 2 wherein the antioxidant is ascorbic acid or a derivative of ascorbic acid.

### Claim 5 (depends on 4)

The composition of claim 4 wherein the antioxidant is ascorbyl palmitate.

### Claim 6 (depends on 1)

The composition of claim 1 wherein the antioxidant is a constituent of ginkgo.

### Claim 7 (depends on 1)

The composition of claim 1 wherein the antioxidant is an isoflavone.

### Claim 8 (depends on 1)

The composition of claim 1 wherein the metallic catalyst is copper in either its cuprous or cupric ionic form.

### Claim 9 (depends on 1)

The composition of claim 1 wherein the mixture of essential amino acids (not including cysteine or methionine) comprises:
(a) from about 5% to about 20% of isoleucine;
(b) from about 5% to about 20% of leucine;
(c) from about 10% to about 25% of lysine;
(d) from about 5% to about 20% of phenylalanine;
(e) from about 5% to about 25% of threonine;
(f) from about 5% to about 20% of tryptophan;
(g) from about 10% to about 25% of valine;
(h) from about 5% to about 20% of histidine; and
(i) from about 5% to about 20% of arginine.

### Claim 10 (depends on 1)

The composition of claim 1 wherein the crosslinking agent is a bioflavonoid.

### Claim 11 (depends on 10)

The composition of claim 10 wherein the bioflavonoid is selected from the group consisting of quercetin, quercitrin, kaempferol, kaempferol 3-rutinoside, 3′-methoxy kaempferol 3-rutinoside, 5,8,4′-trihydroxyl-6,7-dimethoxyflavone, catechin, epicachetin, epicachetin gallate, epigallocachetin gallate, hesperidin, naringin, rutin, vixetin, proanthocyanidin, apigenin, myricetin, tricetin, quercetin, naringin, kaempferol, luteolin, biflavonyl, silybin, silydianin, and silychristin.

### Claim 12 (depends on 11)

The composition of claim 11 wherein the bioflavonoid is proanthocyanidin.

### Claim 13 (depends on 12)

The composition of claim 12 wherein the bioflavonoid is silybin.

### Claim 14 (depends on 1)

The composition of claim 1 wherein the crosslinking agent is decorin.

### Claim 15 (depends on 1)

The composition of claim 1 wherein the transepidermal delivery agent is selected from the group consisting of lower alkyl diols, C10-C20 fatty acids and esters thereof, and C4-C20 optionally substituted aliphatic alcohols.

### Claim 16 (depends on 15)

The composition of claim 15 wherein the transepidermal delivery agent is benzyl alcohol.

### Claim 17 (depends on 1)

The composition of claim 1 further comprising a chaotropic agent.

### Claim 18 (depends on 1)

The composition of claim 1 wherein the composition further comprises a long-chain fatty acid ester of tocopherol.

### Claim 19

A composition for treatment of the skin comprising:
(a) methionine and cysteine in a quantity sufficient to accelerate restoration of the integrity and fullness of the skin;
(b) a mixture of essential amino acids in a quantity sufficient to accelerate restoration of the integrity and fullness of the skin, the mixture of essential amino acids (not including cysteine or methionine) comprising:
(i) about 8.48% of isoleucine;
